Home / Tags / CAR-T therapy

CAR-T therapy

Visualization of T-cells interacting in a biological setting.

| 3 min read

byAndrea Corona

Closed platforms aim to streamline early T-cell engineering

Automation may help address longstanding bottlenecks in CAR-T and TCR-T development

News

Illustration of interconnected neurons with branching dendrites and glowing synapses, showing the complex structure of a neural network in the brain.

| 3 min read

byDDN editorial team

Weekly Rundown: In $1B deal, AbbVie buys psychedelic depression drug from Gilgamesh

Oral GLP-1 data, srRNA therapies, and decentralized CAR T led drug discovery this week.

News

A rendering of a CAR T cell on a dark blue background.

| 9 min read

byAparna Nathan, PhD

New clinical trial puts in vivo CAR T cells to the test

Two ongoing Phase 1 trials will produce the first human data on these potentially revolutionary cancer drugs.

News

Cancer cell targeted by immune cells in a conceptual illustration of antibody immunotherapy.

| 4 min read

byAbzena

Designing optimized T cell engagers for scalable immunotherapy

Data-led engineering and platform strategies are transforming T cell engagers into scalable, clinically viable cancer therapies.

Articles

| 1 min read

byTiffany Garbutt, PhD

Using the Immune System to Destroy Cancer

Download this eBook from Drug Discovery News to learn about leading immunotherapy drugs in the pipeline and discover new approaches to immunotherapy drug discovery and delivery.

Ebooks

Page 1 of 1 - 5 Total Items

CAR-T therapy

Closed platforms aim to streamline early T-cell engineering

Weekly Rundown: In $1B deal, AbbVie buys psychedelic depression drug from Gilgamesh

New clinical trial puts in vivo CAR T cells to the test

Designing optimized T cell engagers for scalable immunotherapy

Using the Immune System to Destroy Cancer

Subscribe to our eNewsletters

Sponsored

December 2025